Mammary epithelial cells are embedded in a unique extracellular environment to which adipocytes and other stromal cells contribute. Mammary epithelial cells are critically dependent on this milieu for survival. However, it remains unknown which adipocyte-secreted factors are required for the survival of the mammary epithelia and what role these adipokines play in the process of ductal carcinoma tumorigenesis. Here, we take a systematic molecular approach to investigate the multiple ways adipocytes and adipokines can uniquely influence the characteristics and phenotypic behavior of malignant breast ductal epithelial cells. Microarray analysis and luciferase reporter assays indicate that adipokines specifically induce several transcriptional programs involved in promoting tumorigenesis, including increased cell proliferation (IGF2, FOS, JUN, cyclin D1), invasive potential (MMP1, ATF3), survival (A20, NFjB), and angiogenesis. One of the key changes in the transformed ductal epithelial cells associated with the cell cycle involves the induction of NFjB (five-fold) and cyclin D1 (three-fold). We show that by regulating the transcription of these molecules, the synergistic activity of adipocyte-derived factors can potentiate MCF-7 cell proliferation. Furthermore, compared to other stromal cell-secreted factors, the full complement of adipokines shows an unparalleled ability to promote increased cell motility, migration, and the capacity for angiogenesis. Adipocyte-secreted factors can affect tumorigenesis by increasing the stabilization of pro-oncogenic factors such as b-catenin and CDK6 as a result of a reduction in the gene expression of their inhibitors (i.e. p18). An in vivo coinjection system using 3T3-L1 adipocytes and SUM159PT cells effectively recapitulates the host-tumor interactions in primary tumors. Type VI collagen, a soluble extracellular matrix protein abundantly expressed in adipocytes, is further upregulated in adipocytes during tumorigenesis. It promotes GSK3b phosphorylation, b-catenin stabilization, and increased b-catenin activity in breast cancer cells and may critically contribute towards tumorigenesis when not counterbalanced by other factors.
Introduction
The past few years have provided substantial evidence for the vital role of the local environment of an emerging tumor for various steps of tumorigenesis, including proliferation and local invasion. Phenotypic behavior of malignant cells is regulated not only by cell autonomous signals, but also by effects exerted from surrounding stromal cells. These signals come in the form of soluble secreted factors, extracellular matrix components, and direct cell-cell contact. The processes of heterotypic signaling involve constant bidirectional crosstalk between normal cells and partially or fully transformed malignant cells (Hanahan and Weinberg, 2000) . Stromal cells, such as fibroblasts, endothelial, and various inflammatory cells, can influence the level of invasiveness and malignancy, whereas tumor cells, in turn, can influence host cells to secrete factors to elicit a more advantageous microenvironment for cancer cell survival Werb, 1996, 2001; Coussens et al., 2000) .
Many in vitro and in vivo studies have begun to elucidate the mechanisms by which stromal cells modify tumor behavior in various microenvironments. An ability to recapitulate the host-tumor interactions is one of the first steps towards dissecting this generalized phenomenon (Hayward et al., 2001; Matrisian et al., 2001) . For example, different experiments by Fidler et al. verified the importance of the tumor microenvironment in regulating properties such as tumor growth, metastasis, angiogenesis, and even drug susceptibility (Fidler, 2001a, b, c) . Various other groups have demonstrated the importance of stromal cell-secreted factors such as matrix metalloproteases (MMPs), growth factors (IGF, VEGF, FGF, etc.) , and the TGF superfamily in modulating tumor behavior (Coussens et al., 2000; Cunha et al., 2000; Hansen and Bissell, 2000; Park et al., 2000; Sternlicht et al., 2000; Matrisian et al., 2001) .
The adipocyte represents one of the most abundant cell types surrounding breast cancer cells and may prove to be a key player in the stromal-ductal epithelial cellcell interactions within the mammary microenvironment. Most primary breast tumors originate from ductal or intraductal epithelial cells. A number of groups have reported a strict dependence of breast cancer cell viability on surrounding stromal cell types in vivo (Johnston et al., 1992; Rahimi et al., 1994; Heber et al., 1996; Chamras et al., 1998; Rahimi et al., 1998; Zangani et al., 1999) . Most of the studies focusing on cell-cell signaling mechanisms in the context of breast cancer have emphasized fibroblasts, myelofibroblasts, macrophages, and other inflammatory cells. Very little attention has been given to the adipocyte, arguably the most abundant stromal cell in the breast.
In the 1980s and early 1990s however, a number of groups attempted to define how mammary adipose tissue could influence breast cancer development. Elliott et al. (1992) showed that the adipocyte-rich environment could facilitate SP1 (a murine mammary carcinoma cell line) growth after injection into mice. When the SP1 cells were injected subcutaneously or peritoneally distant from any fat pads, no growth or metastases were observed; addition of adipose tissue with the SP1 injections into the peritoneal cavity and subcutaneous regions led to tumor growth and metastasis. Further studies revealed that adipocytes promote the estrogendependent growth of SP1 cells (Elliott et al., 1992) . In vitro work by Johnston et al. (1992) demonstrated that both preadipocytes and adipocytes have the potential to affect growth and development of malignant breast cells.
The importance of adipose tissue interactions with normal, nontransformed mammary epithelial cells in promoting growth and development of spherical, ductlike organized structures is well established phenomenologically (Schmeichel et al., 1998) . Many groups have shown that mammary ducts do not form properly without the appropriate interactions with adipose tissue and have identified various signaling mechanisms involved in this process (Howlett and Bissell, 1993; Zangani et al., 1999; Huss and Kratz, 2001) . However, it is not known how adipocytes influence breast tumor cell behavior or whether any of the paracrine factors secreted by adipocytes cause changes in the phenotypic behavior of the malignant cells.
Murine mammary fat is physically closer to ductal epithelial cells than human fat, potentially reducing the clinical implications of our findings shown below. However, in many human breast cancer cases, there is reduced connective tissue separating fat from tumor cells. Furthermore, many tumors break through the basement membrane and infiltrate fibrous tissue barriers, resulting in immediate proximity to adipocytes. For this reason, we have focused on how adipocytesecreted factors could influence all aspects of tumorigenesis, from promoting local invasion to angiogenesis and metastasis to distant sites that are fat enriched (such as the bone marrow).
Furthermore, one of the reasons why the adipocyte received relatively little attention was the view that it is merely an energy-storing cell, relatively inert to its surroundings. Work by many different laboratories over the course of the past few years has, in fact, shown that the adipocyte is a highly active endocrine cell that secretes numerous factors, including growth factors, cytokines, hormone-like molecules, acute phase reactants, complement-related proteins, and extracellular matrix proteins (Scherer et al., 1995; Mohamed-Ali et al., 1998; Scherer et al., 1998; Ahima and Flier, 2000; Bickel et al., 2000; Engelman et al., 2000; Havel, 2000; Lin et al., 2000b Lin et al., , 2001b Berg et al., 2001 ). The adipocyte is therefore an excellent candidate cell to play an important role in influencing tumor behavior through heterotypic signaling processes and may prove to be critical for tumor survival, growth, and metastasis in the breast. Using a recently described novel technique, termed subtractive antibody screening (SAS), we identified a host of factors that were previously known but whose enrichment and expression in adipose tissue escaped detection. Such components include osteonectin (SPARC), EMMPRIN, and Type VI collagen .
Type VI collagen, in particular, may play an important role in the context of heterotypic signaling. Collagen VI is a soluble protein that can be categorized as a fibrillar-based collagen as well as an interstitial collagen. Several papers in the last few years have described a possible role for this protein in cell proliferation in the context of other cancer types. It has been implicated in the regulation of normal and transformed mesenchymal cell proliferation in vitro (Atkinson et al., 1996) and reported to prevent apoptosis (Ruhl et al., 1999) . Other groups also identified Type VIa3 collagen as one of the genes upregulated in stromal endothelial cells when associated with colorectal tumors (St Croix et al., 2000) . Most recently, Herlyn and colleagues identified collagen VI as one of a small number of genes upregulated in stromal cells as a direct consequence of exposure to melanoma cells overexpressing TGFb (Berking et al., 2001a) . Hence, multiple groups have recognized the potential link between collagen Type VI and tumorigenesis.
Among the many signaling pathways intimately associated with tumorigenesis, the PKB-GSK3b/bcatenin-TCF/LEF pathway has been the focus of much attention. Originally shown in colon carcinomas, but now also identified as an important regulatory pathway in breast tumors (Michaelson and Leder, 2001) , the activation of TCF/LEF-driven transcription of various pro-oncogenic genes (cyclin D1, NFkB, cFOS, ATF3) is a critical element in the conversion to malignancy. Any process leading to an accumulation of cytoplasmic and hence increased nuclear levels of b-catenin increases TCF/LEF activity (Brantjes et al., 2002) . Such processes include increased production of b-catenin (less common), increased phosphorylation of GSK3b (which only in its unphosphorylated state causes b-catenin degradation), or mutations in b-catenin that prevent binding to GSK3b.
Using DNA microarray technology, we have determined that discrete transcriptional programs are specifically induced upon exposure of MCF-7 cells to secreted factors (adipokines) from adipocytes. The genes affected by the adipokines can be grouped into different categories and are generally involved in the promotion of tumor growth, invasion, and metastasis. Several functional assays support the notion of adipokine promotion of transformed ductal epithelial cell development and survival as a potential consequence of the transcriptional changes. These gene-expression changes are unique to adipocyte-secreted factors and cannot be recapitulated by other breast stromal cells. Subsequently, we have developed an in vivo model to demonstrate the capacity of adipocytes to promote tumor growth. Finally, we have focused on one adipocyte-enriched secretory protein, Type VI collagen, and show that this molecule can cause the specific phosphorylation of GSK3b in breast cancer cells. The phosphorylation of GSK3b leads to increased b-catenin stabilization and activity, thereby promoting proliferative processes. Combined, these findings shed light on the complicated crosstalk between adipocytes and breast cancer cells and underscore the important role that heterotypic signaling plays in modulating tumor behavior in the breast.
Materials and methods

Materials
Dulbecco's Modified Eagle's Medium (DMEM) was prepared at the Albert Einstein Cancer Center Media preparation facility. Unless noted, all other chemicals were purchased from Fisher and Sigma.
Cell culture 3T3-L1 murine fibroblasts (a generous gift of Dr Charles Rubin, Albert Einstein College of Medicine) were propagated and differentiated as previously described (Engelman et al., 1998) . In brief, the fibroblasts were propagated in 10% fetal calf serum (FCS) medium (DMEM, 10 FCS (JRH Biosciences) and antibiotics (penicillin/streptomycin -100 U/ml each) and allowed to reach confluence (Day À2). After 2 days (Day 0), the 10% FCS was changed and new 10% FCS was added to the cells with the addition of 160 nm insulin, 250 nm dexamethasone, and 0.5 mm 3-isobutyl-1-methylxanthine (this new medium called DM1). After 2 days (Day 2), the DM1 medium was replaced with fresh 10% FCS containing only 160 nm insulin (DM2). After another 2 days, the cells were then propagated in only 10% FCS medium. NIH-3T3 cells were grown and propagated in DME containing 10% donor calf serum and antibiotics. SUM-159PT cells were grown in 5% charcoal-stripped FCS, in Ham's F-12 Nutrient Media with sodium bicarbonate, 10 mm HEPES, and 25 mm glucose (Flanagan et al., 1999) . The SUM-159PT medium was pH adjusted to 7.1. hTERT-HME1 cells were purchased from Clontech Inc. and grown as per the manufacturer's instructions.
Proteins
Purified (to 99.9% homogeneity) human type VI collagen was obtained from Research Diagnostics (Flanders, NJ, USA). Purified Type I collagen was obtained from Collaborative Biomedical Products of Bedford, MA, USA. Type VI and I collagens were used at a concentration of 30 mg/ml, unless otherwise stated.
Total RNA isolation, Northern blot analysis and RT-PCR
Total RNA from tissue and cultured cells was isolated with Trizol (Life Technologies). Total RNA (20 mg) was for Northern blot analysis as described (Baldini et al., 1992) . Blots were prehybridized in Ultrahyb (Ambion) for 2 h at 421C. Denatured [ 32 P]-DNA probes were added (2 Â 10 6 c.p.m./ml) and blots were hybridized overnight at 421C. The filters were washed in 2 Â SSC/0.1% SDS ( Â 2, 10 0 ) and 0.1 Â SSC/0.1% SDS ( Â 2, 5 0 ) at 421C before autoradiography.
Antibodies
Monoclonal antibodies to b-catenin and CDK6 were obtained from Transduction Laboratories, Lexington, KY, USA. Phospho-specific antibodies for GSK3b (Ser9) were obtained from New England BioLabs.
Immunoblotting
Separation of proteins by SDS-PAGE, fluorography, and immunoblotting was performed as described previously (Scherer et al., 1994) . Briefly, primary and secondary antibodies were diluted in TBS with 0.1% Tween-20 and 1% bovine serum albumin (BSA). Horseradish peroxidase-conjugated secondary antibodies were detected with enhanced chemiluminescence according to the manufacturer's instructions (DuPont-NEN). Under normal conditions, cells in 10 cm dishes were lysed in 3 Â sample buffer þ 100 mm DTT. For Western blots that were to be used for examining phosphorylated protein products, the following phosphatase inhibitors were added to the lysis buffer: 50 mm NaF, 30 mm sodium pyrophosphate, and 100 mm sodium orthovanadate. The lysed cells were then sonicated and boiled for 5 min and eventually loaded on 12.5% SDS-PAGE gels. The gels were run and wet transferred onto nitrocellulose membranes. These membranes were then initially blocked with 4% milk for 30 min and then placed in primary (usually 1/1000) antibody for 3 h at room temperature. After three 5-10 min washes in TBS-Tween 20, the membranes were placed in secondary antibody (1 : 5000, HRP-conjugated) for 1 h at room temperature. Finally, the membranes were washed six to eight times for 3 min each in TBS-Tween and then exposed to ECL solution.
Immunohistochemistry for Type VIa3 collagen
Whole mount mammary glands were fixed with formalin overnight onto a glass slide and then paraffin wax embedded. Sections (5 mm) were subjected to an antigen unmasking treatment by heating slides at 951C for 10 min in 50 mm glycine-HCl buffer (pH 3.5), prior to overnight incubation with the rabbit anti-type VI collagen antibody . After washing in PBS (9.1 mm dibasic sodium phosphate, 1.7 mm monobasic sodium phosphate, 150 mm NaCl, pH 7.4), slides were incubated with the biotinylated goat antirabbit IgG at 5 mg/ml (Vector Laboratories, Burlingame, CA, USA) for 1 h at RT. Slides were finally developed using a peroxidase detection kit (Vector Laboratories, Burlingame, CA, USA) and counterstained with hematoxylin (Sigma Chemicals, St Louis, MO, USA).
In situ hybridization
A unique C-terminal 500 bp fragment of murine type VIa3 collagen was amplified from a 3T3 L1 Day 8 cDNA library. The primers used were as follows (incorporating 5 0 T7 and 3 0 SP6 sites for transcription): Type VIa3 collagen forward primer -5 0 -CCT AAT ACG ACT CAC TAT AGG GCG GTC TCC AGG CTC TGC TGC TTA GAG G-3 0 Type VIa3 collagen reverse primer -5 0 -ATT TAG GTG ACA CTA TAG AAG GAG AGA CGG GAG ATG ACG G-3 0 . After amplification and isolation, DNA was transcribed into RNA using an in vitro transcription system (Riboprobe; Promega) with digoxigenin-derivatized UTP. Both sense and antisense RNAs were used as probes for the subsequent hybridization steps.
Sections for the in situ hybridizations were obtained from mouse polyoma middle T-MMTV mammary tumor models at various stages of malignancy. The fresh tissues taken from the animals were frozen in OTC, briefly fixed in 4% paraformaldehyde/PBS, embedded, and sectioned at approximately 15 mm. After the hybridization, the labeled probes were visualized using a Digoxigenin Nucleic Acid Detection Kit (Roche).
Microarray analysis
Initially, a subconfluent plate of MCF-7 cells was treated with conditioned media isolated from 3T3-L1 adipocytes, 3T3-L1 fibroblasts, or NIH-3T3 fibroblasts for a period of 12 h. Trizol was then used to isolate total RNA. Human microarrays (9596 spots) from the Albert Einstein College of Medicine Microarray Facility were obtained and used for experimentation. Total RNA (100 mg) was reverse-transcribed with the concomitant incorporation of Cy3-and Cy5-labeled nucleotides. As per the protocol standardized by the Albert Einstein College of Medicine Microarray Facility, the labeled, reversetranscribed RNA was incubated on the microarrays and subsequently analysed using Scanalyze software. Each independent experiment utilized data from three separate chips and three separate RNA isolations as well as a reversal of the incorporated labeled nucleotides. A threshold value of 1.5-2-fold above background in either direction was specified before analysis of individual genes. Only genes that overlapped on all sets of chips were reported. Standard deviation and standard error were calculated for the gene fold changes.
Conditioned media system
The conditioned media was isolated in the following way. Confluent 3T3-L1 adipocyte, 3T3-L1 fibroblast, or NIH-3T3 plates were identified, the 10% FCS removed, the plates washed two times with sterile PBS, and 3-5 ml of serum-free DME-BSA (from Gibco-BRL) added to the plates and incubated for approximately 8 h. After the incubation, the DME-BSA was collected and centrifuged at 14 000 Â g to remove cellular debris. The centrifuged conditioned media was then placed on MCF-7 cells for variable periods of time as indicated in the respective experiments. Often, to prevent the treated MCF-7 cells from becoming sick due to harmful metabolites that may have leached into the DME-BSA, low levels of serum (0.1% CS or 0.1% FCS) were added to the conditioned media (protective agent). This small amount of serum was added across all samples. Delipidated BSA (cold ethanol precipitated fraction V -Sigma) was used in the conditioned media preparations.
FACS analysis
FACS analysis was used for determining cell cycle progression of the MCF-7 cells after treatment by various secreted factors. For cell cycle analysis, the cells were trypsinized and spun down after treatment. The cells were then washed twice with PBS and then fixed and resuspended in 70% ethanol at 41C for 3 h or overnight. Next, the cells were washed with PBS and finally resuspended in a PBS-based solution containing 10 mg/ ml RNase I and 50 mg/ml propidium iodide. Subsequently, the samples were incubated at 371C in the dark and then FACS analysed for cell cycle progression.
Luciferase assays
Initially, equal numbers of MCF-7 cells were seeded in 12-well plates such that a density of 50-60% confluence is obtained the next day. In general, 2 days prior to the luciferase assay, MCF-7 cells were transiently transfected with an NFkB luciferase construct as well as a thymidine kinase driven renilla luciferase construct as a transfection control vector. Superfect transfection reagent was used and for 12-well plates, 1.5 mg of DNA was transfected per well. The promoter on the NFkB luciferase construct was a consensus NFkB binding sequence. Approximately 30 h after the transfection, adipocyte-conditioned media (Adipo-CM) was added to the MCF-7 cells and treated for 12 h. Subsequently, the MCF-7 cells were processed using a dual-luciferase assay system for luciferase activity from both the NFkB constructs and the renilla constructs. All the results were standardized to the relative transfection efficiencies as observed from the renilla values. The same methods were used for all additional luciferase assays.
Cell migration/invasion assay
A two-level, 48-well cell migration assay chamber was used for these experiments. Initially, conditioned media from adipocytes and fibroblasts as well as DMEM were collected and transferred to the wells of the bottom chamber. A membrane that had been coated with type I collagen for 2 h was placed on top of the bottom chamber. In the top chamber, 5 Â 10 4 MCF-7 cells were transferred to each of the wells. The whole apparatus was incubated at 371C for 4 h. After the 4 h, the membrane was removed and the cells fixed with glutaraldehyde for 2 h. Finally, the fixed cells were incubated in methylene blue overnight and the number of cells that had migrated through the membrane was counted under a microscope.
In vitro angiogenesis assay
A commercial kit (Chemicon Inc.) was used for this assay as per the manufacturer's instructions. In brief, using a 96-well Adipocytes and breast cancer P Iyengar et al plate, 100 ml of matrigel was transferred into each well at 41C. After giving the matrigel time to solidify in a 371C incubator (2 h), approximately 5 Â 10 4 bovine endothelial cells were placed on top of the matrix along with conditioned media from either adipocytes or fibroblasts in addition to 10% FCS. The next day, the wells were observed under a microscope for tube-like formations, indicative of angiogenic processes.
In vivo tumorigenesis and metastasis assay
The reconstituted in vivo tumor model used 3T3-L1 cells in combination with fluorescently tagged SUM-159PT cells. Cells were implanted by subcutaneous injection in the flank of male 6-to 8-week-old, nude mice obtained from Jackson Laboratories. Mice were killed 6 weeks postinjection. After excision, tumor size (area and wet weight) was recorded. Mice received injections of 3 Â 10 5 adipocytes and 1 Â 10 4 SUM-159PT cells. Tumors that formed were measured, excised, and analysed by histopathology. The study protocol was reviewed and approved by the Institutional Animal Care and Use Committee of the Albert Einstein College of Medicine.
Cell proliferation assay
Different malignant breast cell lines were treated with various conditioned media after being seeded in 96-well plates. After the period of treatment, the cells were examined and measured for relative rates of proliferation. Promega's (Madison, WI, USA), CellTiter 96 Aqueous One Solution cell proliferation assay was used according to the manufacturer's recommended protocol.
Results
3T3-L1 adipocytes support survival of transformed ductal epithelial cells in vitro under limiting serum conditions
Our initial experiments aimed to identify conditions that would allow us to study adipocyte interactions with malignant ductal epithelial cells under defined conditions. The premise is that the in vivo cell-cell interactions in breast microenvironments consist of a complex crosstalk that relies on the overall additive effect of numerous molecules (i.e. growth-promoting and -inhibiting) and not simply the result of one single secreted factor. An additional goal was to identify the conditions necessary to perform relevant microarray experiments. We began by determining whether or not coculturing adipocytes and malignant ductal epithelial cells had an impact on the latter's survival and/or growth potential. Up to this point, few studies had attempted to reproduce these effects in tissue culture. SUM-159PT cells (highly metastatic; ERa-negative; Flanagan et al., 1999) and MCF-7 cells (nonmetastatic; ERa-positive) were stably transfected with green fluorescent protein (GFP) and red fluorescent protein (RFP), respectively (Flanagan et al., 1999) . High-level expressors were selected and equal numbers of cells were independently seeded into 6-well plates with 3T3-L1 preadipocytes, confluent 3T3-L1 adipocytes, or unconditioned medium (DME-BSA). The ability of the feeder cell types to regulate SUM-159PT or MCF-7 cell growth, proliferation, and/or survival was monitored by measuring the number of cells expressing GFP or RFP by FACS. Cells were initially seeded by themselves, with confluent fibroblasts, or with fully differentiated adipocytes in the respective optimized growth medium of the breast cancer cell type to promote proper attachment. After 24 h, the medium was changed to 0.1% FCS. The FACS results from Day 1 provided a baseline for the number of breast cancer cells seeded with the feeder cell line. Fresh conditioned medium containing 0.1% FCS was provided every 48 h. The results for SUM-159PT cells illustrated to us that Adipo-CM had the unique ability to support tumor cell survival. Similar effects were seen for MCF-7 cells (data not shown). Measurements obtained 5 days later indicated that both feeder cell types, fibroblasts and adipocytes, maintained cell survival. Measurements obtained after 7 days indicated that malignant cells cultured with adipocytes continued to survive, whereas the percentage of fluorescent-positive cells incubated with fibroblasts decreased. While both fibroblast and adipocyte layers could overcome the low serum conditions and stimulate low-level proliferation of breast cancer cells for short periods of time, fibroblasts were unable to sustain survival upon longer incubation. Importantly, cell viability of both fibroblasts and adipocytes was not differentially affected under these conditions, as judged by trypan blue staining at the last time point (not shown).
To study more acute effects and to be able to investigate transcriptional changes in breast cancer cells in the absence of the supporting cell type, cells were grown in conditioned media as opposed to coculture experiments. To establish these conditions, MCF-7 cells were incubated in the presence of various conditioned media conditions: either DMEM þ 10% calf serum (CS) (standard growth conditions for our MCF-7 cells), DMEM þ 10% FCS or DMEM þ 10% FCS conditioned with factors secreted by adipocytes or fibroblasts. In 10% CS, MCF-7 cells grow normally. In 10% FCS, the cells underwent apoptosis within a short period of time (o48 h). Adipokine-enriched 10% FCS sustained survival of the MCF-7 cells (data not shown). We therefore decided to use this system as a paradigm for the initial analysis of the heterotypic signaling events between adipocytes and breast ductal epithelial cells ex vivo.
Transcriptional programs activated in MCF-7 cells in response to adipokines
Using the above-described in vitro system, we determined the influence of adipokines and total adipocytesecreted factors on transcriptional events in MCF-7 cells. In our conditioned media assay, 3T3-L1 adipocytes were allowed to secrete factors into serum-free medium ('DME-BSA'). After 8 h, medium was collected and applied to MCF-7 cells for 12 h ('Adipo-CM'). MCF-7 cells were subsequently trypsinized and total RNA was isolated. This total RNA was used for DNA microarray hybridizations. Similar preparations were generated from MCF-7 cells treated with serum-free medium conditioned with NIH-3T3 fibroblasts, 3T3-L1 fibroblasts, as well as nonconditioned medium (DME-BSA).
Three independent reactions were performed for each condition, using RNA from separate experiments. The goal of these experiments was to determine the extent to which Adipo-CM has a unique impact and influence on MCF-7 gene expression when compared to the effects of various types of fibroblast-secreted factors. To more closely recapitulate the stromal cell-tumor cell interactions, we decided not to utilize cycloheximide in this set of experiments. Hence, we measured secondary and tertiary effects of different gene induction programs that also make an important contribution to the functional/phenotypic characteristics of the tumor cells in vivo.
The microarrays revealed a striking and easily interpretable data set. Even with a high threshold value (set 4 or otwofold intensity over background), the adipocyte-secreted factors were able to induce many positive and negative transcriptional changes in the breast cancer cells. The fibroblast-secreted factors at such thresholds were also able to affect different genes, but the number of genes induced and the magnitude of the changes were far less than the adipocyte effects. Interestingly, a subset of genes was uniquely upregulated and downregulated by the Adipo-CM in MCF-7 cells (Table 1) . Only genes that are specifically affected by adipocyte-secreted factors (but not by both adipocyteand fibroblast-conditioned medium (Fibro-CM)) are represented in this table. Importantly, this table represents an unbiased list of genes most highly upregulated. Furthermore, all of the top 13 genes most highly upregulated by the 'Adipo-CM' in the MCF-7 cells are associated with either increased malignant, invasive, or proliferative potential. Many other genes that were upregulated by the Adipo-CM also promote tumorigenesis, but changes in their expression levels were more moderate. The other highly upregulated genes are considered to have cellular housekeeping functions. The induction of several of these genes (ATF3, NFkB, MMP1, SOX9, Stanniocalcin) was confirmed by Northern blot analysis. Genes encoding transcription factors, proto-oncogenes, extracellular matrix proteins, growth factors, and synthetases, etc. were the most uniquely affected by the adipocytesecreted factors. All of these groups have been known to be extremely active in proliferative cell types.
In addition to the many genes that were upregulated, there were several genes downregulated. The groups most affected included genes for cell-cycle checkpoint molecules, some transcription factors, and others. The net effect of the downregulation of these genes could also contribute to increased malignant, metastatic, and proliferative potential of the MCF-7 cells (Table 2 ).
All the gene expression changes seen with the microarray analysis provide a general view of the influence that adipokines exert acutely on the phenotypic behavior of breast cancer cells. In our experiments, a large number of transcriptional changes support the notion that Adipo-CM promotes increased invasive, angiogenic, and proliferative capacities in breast cancer cells, all of which lead to increased survival and malignancy (Table 3) .
Numerous secreted molecules from many different cells act in a coordinated fashion to affect the transcription of important genes in malignant cells throughout the breast microenvironments. In vitro microarray data is a powerful indicator for global transcriptional changes. However, caution has to be exercised with respect to the interpretation of the results, and independent functional readouts have to be sought to confirm the observations made at the array level. How do these changes, when combined, alter the phenotypic and functional characteristics of the tumor cells? How do the transcriptional changes translate into changes at the protein level? It is possible that a 20-fold change in one gene is not as significant to the functional phenotype as a threefold change in another gene. Based on the fact that the Adipo-CM appears to uniquely induce a number of pro-tumorigenic genes at high levels, it was important to determine the functional consequences of these transcriptional readouts. Cell adhesion and extracellular matrix interactions (Liotta et al., 1983; Liotta, 1988; Fridman et al., 1991 Fridman et al., , 1992 Sweeney et al., 1991; Christensen, 1992; Gui et al., 1997) +15.4-fold74.5 SOX9 Closest relative of a protein associated with increased metastatic potential in melanomas (Tani et al., 1997; Huang et al., 2000; Cheng et al., 2001) +11.8-fold72.3
IGF-2 Insulin-like growth factor (Peyrat et al., 1988; McCann et al., 1996; Ellis et al., 1998; Rasmussen and Cullen, 1998) +8.4-fold70.32
Stanniocalcin Upregulated during the course of angiogenesis and estrogen treatment of MCF-7 cells (Charpentier et al., 2000; Fujiwara et al., 2000; Jellinek et al., 2000; Lal et al., 2001) +8-fold70.78
HEM45
Mediator of estrogen regulation of cell proliferation and cell-cycle progression (Pentecost, 1998) +8-fold72.1
Integrin, alpha 2 Mediates interactions during invasion (Liotta, 1988; Gui et al., 1997; Shaw, 1999; Achison et al., 2001; Berking et al., 2001b; Ross et al., 2001) +5-fold70.53
NFkB Survival and inflammation +5-fold70.49
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Functional analysis of the effect of Adipo-CM on malignant breast ductal epithelial cells utilizing FACS
The microarray analysis described global transcriptional changes. As a next step, we examined how these transcriptional changes translated into changes at the level of cellular homeostasis in breast ductal epithelial cells. FACS analysis was used to determine the extent that 3T3-L1 adipocyte-conditioned media affected the cell cycle in both MCF-7 (estrogen receptor positive) and MDA-MB 231 (estrogen receptor negative, more invasive) breast cancer cells. The rationale for doing so included the fact that many mitogens and growth factors were uniquely upregulated in the breast cancer cells upon Adipo-CM treatment (IGFII, HEM45, and HMR and others). Similar to the conditions used for microarray analysis, we collected adipocyte-secreted factors for a period of 8 h. These conditioned media preparations were added to both breast cancer cell types for a 12-h treatment period. After the incubation period, the breast cancer cells were prepared for cellcycle FACS analysis. Each experiment was performed in triplicate. The percentage changes indicated represent an average of at least three independent experiments. As previously described, serum-free DME-BSA was used as a control alongside the conditioned media samples. FACS analysis revealed a significant change in the number of cells that were in S phase (Table 4) . Specifically, the samples that received Adipo-CM showed an increase in the S phase population by 39% (MCF-7) and 53% (MDA-MB-231), respectively, compared to controls. Overall, samples that received either Fibro-CM or DME-BSA had approximately 18% of total cells in S phase. The MCF-7 cells that received Adipo-CM had approximately 25% of total cells in S phase and the MDA-MB 231 cells that also received Adipo-CM had approximately 26.4% of total cells in S phase. In order to verify that the changes in S phase seen were attributable to increased cell proliferation and not increased S phase duration, cell proliferation assays were performed. The assays illustrated the fact that the breast tumor cells treated with Adipo-CM and subsequently displaying increased populations in S phase was a result of increased numbers of proliferative cells. The cells treated with Fibro-CM had fewer cells proliferating and hence less numbers of cells in S-phase.
One of the important consequences of increased entry into S phase is cellular survival and progression through the G1/S checkpoint. A cell progressing through S phase of the cell cycle indicates that signals promoting survival and preventing apoptosis have been provided. Furthermore, increased progression through S phase of the cell cycle is a hallmark of proliferation. The adipocyte may be providing such signals that consequently lead to increased number of cells in S phase of the cell cycle. Consistent with this observation, the microarray data demonstrated the upregulation of NFkB and the downregulation of CDK6 inhibitor p18, both providing a possible explanation for the increase in cells in S phase. Increased NFkB upregulates expression of cyclin D1 and decreased p18 facilitates increased formation and stabilization of cyclin D1-CDK4/6 complexes, vital for entry into S phase. Furthermore, the induction of antiapoptotic pathway genes A20 (approx. 50-fold) and NFkB (approx. fivefold) was confirmed upon examining MCF-7 cells under limited growth factor conditions that showed a dramatically improved survival rate in the Decreased BARD1 -will reduce the ability of BRCA1 to function as a tumor-suppressor gene. Decreased BUB1 kinase, decreased expression of proteins involved in the mitotic spindle checkpoint -increased number of MCF-7 cells that can bypass specific checkpoints in the cell cycle to survive.
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Functional confirmation of Adipo-CM effects on MCF-7 cells using promoter studies
To further corroborate the results from the microarray analysis, we used luciferase reporter and gel shift assays for a select set of target genes. One of the targets tested was an NFkB-responsive luciferase construct. MCF-7 cells were transiently transfected with an NFkB luciferase construct. At 30 h post-transfection, Adipo-CM was added to the MCF-7 cells for an additional 12 h. Subsequently, the MCF-7 cells were processed using a dual-luciferase assay system. All results were standardized to the relative transfection efficiencies, using a TKrenilla construct. Compared to MCF-7 cells that received conditioned media from either NIH-3T3 cells or 3T3-L1 fibroblasts, cells exposed to Adipo-CM showed a 5-6 fold greater induction of NFkB luciferase activity (Figure 1 ). This result is consistent with the microarray analysis that showed that Adipo-CM induces an approximately fivefold increase in NFkB gene expression compared to cells that just received serum-free DME-BSA. This result was further confirmed by electrophoretic mobility shift assays (EMSAs) using NFkB-specific oligonucleotides (data not shown). Additional luciferase assays were performed for cyclin D1, c-FOS, AP1, and c-JUN promoter activity. All of these factors are important transcription factors/coactivators involved in various stages of tumorigenesis and are often highly expressed in many tumor cell lines. Compared to baseline activity, Adipo-CM induced the transcription of all reporters more than any other treatment from other stromal cell types. Specifically, cyclin D1 activity was induced approximately threefold. Increased cyclin D1 levels can increase S phase entry of MCF-7 cells. The two-to threefold rise in c-FOS induction as a result of Adipo-CM could reflect a similar change observed with a FOS-related molecule (up approx. 2.2-fold in microarray experiments).
Effect of Adipo-CM on critical proteins involved in tumorigenesis
All of the experiments so far were aimed at assessing how adipocyte-secreted factors affect transcriptional events in malignant cell lines and alter cellular processes that promote tumorigenesis. We also wanted to assess whether adipocyte-secreted factors can influence tumor cells at the level of protein stabilization. We chose two Identical results were obtained with DME-BSA treatment control (only MCF-7 cells).
Mean7s.e.m. *Po0.05. Each sample is an average of four separate experiments. % Prol. cells refers to the percentage of total cells that were proliferating after the indicated treatment as determined by tritium incorporation or the MTT proliferation assay (Promega). The 100% proliferation standard was set for tumor cells grown/treated in 10% CS Figure 1 Effects of Adipo-CM and Fibro-CM on MCF-7 transcriptional activity. Luciferase reporter plasmids containing NFkB responsive elements (a), the cyclin D1 promoter (b), AP1-(c), cFOS-(d) and cJun-(e) responsive elements were transiently transfected into MCF-7 cells. After 36 h, the various conditioned medias were added to the cells for 12 h. Subsequently, the cells were lysed and prepared for the luciferase assay. A TK-renilla construct was cotransfected and measured in the assay to control for differences in transfection efficiency. (Michaelson and Leder, 2001 ). Furthermore, a focus on these proteins made sense in light of our microarray results, which showed a downregulation of their respective inhibitors (i.e. p18, INK4). Our previous studies demonstrate that factors secreted from adipocytes have unique effects on transformed breast ductal epithelial cells. What has not been determined, however, is whether or not Adipo-CM can also influence the behavior of either normal ductal epithelial cells or more interestingly, cells that have been immortalized but not transformed. For this purpose, we used the MCF-7 and hTERT-HME1 cell lines, respectively. This latter mammary ductal epithelial cell line is stably transfected with human telomerase that results in immortalization. We examined protein expression of bcatenin after treatment with the respective conditioned media. As with all the previous experiments, Adipo-and Fibro-CM were collected and incubated with the different cells for a period of 12 h. After the treatment, protein extracts were prepared and analysed by Western blotting with antibodies to b-catenin. The membrane was also probed with a control antibody against GDI (Scherer et al., 1997) to ensure equal protein loading. There was 3-4-fold more b-catenin protein in the samples of MCF-7 and hTERT cells that received Adipo-CM vs Fibro-CM. This increase of b-catenin is consistent with a more aggressive growth pattern of these cells upon exposure to Adipo-CM (Figure 2a) . Data presented later in the paper suggest that collagen VI, which is highly enriched in the matrix surrounding the adipocyte, induces GSK3b phosphorylation, leading to increased b-catenin stability and TCF-LEF activity and may be one of the factors responsible for the effects seen with the conditioned supernatant experiment.
In the context of MCF-7 cells, we also tested the effects of Adipo-CM on the expression level of CDK6. Like b-catenin, CDK6 is regulated transcriptionally as well as at the level of phosphorylation (Sherr and Roberts, 1999) . Increased levels of CDK6 are associated with a more metastatic phenotype (Sherr, 1994) . The microarray data demonstrated the downregulation of the CDK6 inhibitor p18. We therefore tested whether Adipo-CM has an effect on CDK6 levels. Indeed, MCF-7 cells expressed significantly higher levels of CDK6 after a 12-h incubation in Adipo-CM compared to either fibroblast CM or DME-BSA alone (Figure 2b ). Increased CDK6 levels promote formation of more CDKcyclin D1 complexes, thereby facilitating cell entry into S phase of the cell cycle and greater cell proliferation.
Effect of Adipo-CM on MCF-7 cell migration
Several of the genes (MMP1, MMP2, stanniocalcin, SOX9, integrins) shown to be upregulated in the microarray analysis have the potential to increase the invasive phenotype of transformed ductal epithelial cells. One of the first indicators of increased cellular invasion is increased cell motility. We thus decided to examine the possibility that factors secreted from adipocytes induce MCF-7 cells to migrate at a higher rate through a matrix of extracellular components. A classical cell migration/invasion assay was used to test this possibility. Normally, this malignant ductal epithelial cell line is not very invasive. Therefore, any effect that could promote cell motility should be viewed as quite significant. MCF-7 cells were separated from another chamber filled with adipocyte CM, fibroblast CM, or unconditioned medium by a filter coated with Type I collagen. The cells were given 5 h to migrate through the membrane towards the conditioned media. At the end of the experiment, the membrane filter was removed and the bottom surface was fixed, stained and counted. The Adipo-CM exerted a significantly more powerful effect (4fourfold) than 3T3-L1 fibroblast CM or unconditioned medium in stimulating migration of the malignant cell type. These data suggest that adipocyte-secreted factors affect the chemotactic or possible invasive potential of MCF-7 cells, in the process promoting tumorigenic characteristics (Figure 3 ).
An additional assay was used to measure cell migration. In a wound-healing assay, factors secreted by different cell types were assessed for their capacity to initiate and promote endothelial cell movement. A zone free of cells was generated in a dish containing otherwise near confluent bovine aortic endothelial cells. Cells exposed to Adipo-CM moved the farthest in either direction to close the gap in the cell bed. The fibroblastsecreted factors and the 10% FCS did little to promote net movement in the endothelial cells (data not shown). The results from the microarrays suggested that adipocytesecreted factors could also promote angiogenesis, another element of tumorigenesis. Among the many factors that were upregulated and also associated with angiogenesis included stanniocalcin, aminoacyl tRNA synthetases (specifically the tyrosyl-tRNA synthetase), etc. Castellot et al. (1982) , and Barger and colleagues (Silverman et al., 1988) had previously used other assays to demonstrate the potential of adipocyte-secreted factors to promote angiogenesis. One of the factors they identified was monobutyrin (Dobson et al., 1990) . To further address this issue in a more recently established system, we utilized an in vitro angiogenesis assay to measure the ability of Adipo-CM to cause bovine endothelial cells to form tube-like structures on an extracellular matrix substrate. Unlike previous studies, we were also interested in determining how much better, if at all, adipocyte-secreted factors could promote angiogenesis when compared with factors from other classical stromal cells. Overwhelmingly, adipokines had the greatest effect in inducing the endothelial cell tube formation when compared to either fibroblast-secreted factors or 10% FCS (Figure 4 ).
An in vivo tumorigenesis and metastasis model using the established 3T3-L1 adipocyte cell line
To further assess the ability of adipocytes to influence tumor development and/or progression, we performed reconstitution experiments in athymic nude mice. The goal of the in vivo experiments was to support the in vitro data we collected, which illustrated the capacity of specifically adipocyte-secreted factors to promote various aspects of tumorigenesis (foci formation, tumor Migration assay assessing movement of MCF-7 cells towards conditioned media from three different sources: Fibro-CM, Adipo-CM, and DME-BSA. Initially, collected Adipo-CM and Fibro-CM were isolated and aliquoted into the bottom wells of the twochamber chemotaxis apparatus. MCF-7 cells were seeded in the top wells and were assessed for their ability to migrate through a collagen I-coated membrane towards the potential chemoattractants. Note that Adipo-CM stimulates migration dramatically.
Mean7s.e.m. *Po0.05, each sample is an average of three separate experiments performed in triplicate Figure 4 Adipo-CM stimulates angiogenesis in vitro (endothelial capillary tubule formation). An angiogenesis assay was used to measure the capacity of various conditioned media to promote new blood vessel formation. FCS (10%) was conditioned with either adipocyte-secreted factors, fibroblast-secreted factors, or left alone and mixed with bovine endothelial cells before being seeded on Matrigel in 96-well plates. After overnight exposure, the wells were photographed to determine the extent of tube formation. No tube formation was identifiable after 0 h. The panel represents tube formation after 16 h Adipocytes and breast cancer P Iyengar et al development, angiogenesis, etc.). We successfully reconstituted this in vivo tumor model using the same 3T3-L1 cell line that we also used for the in vitro studies. 3T3-L1 cells were used in combination with fluorescently tagged SUM-159PT cells.
Here we show that fully differentiated 3T3-L1 adipocytes offer optimal growth conditions for SUM-159PT cells subcutaneously. In contrast, coinjection of 3T3-L1 fibroblasts results in only very modest tumor growth, even in the presence of Matrigel (Fridman et al., , 1992 Sweeney et al., 1991) (data not shown). Furthermore, we chose to inject a low-enough titer of SUM-159PT cells so that they were unable to form tumors on their own subcutaneously (approximately 1 Â 10 4 cells). At the first week of postinjection of cells, there was no visible formation of tumor masses in any mice. At the 2-week mark, mice exposed to a mixture of breast cancer cells and 3T3-L1 adipocytes had small tumor-like masses at the sites of injection. By week 5, the tumors had reached an average volume of 8327100 mm 3 in the presence of 3T3-L1 adipocytes, whereas the masses in the mice that received some combination of 3T3-L1 fibroblasts þ breast cancer cells þ Matrigel had an average tumor volume in the 80715 mm 3 range. Mice that received only malignant ductal epithelial cells showed no obvious tumor growth. While Matrigel had little effect on tumor size, it did affect the shape of the tumors, allowing for one large primary mass rather than a more multilobular formation found in the absence of the extracellular matrix component. During the course of the experiment, tumor size was monitored and recorded as a function of time (Figure 5a ). At the end of the experiment, primary tumors, lung and liver (for the detection of metastases) were excised, fixed, and analysed by immunohistochemistry for the presence of the human ErbB2/Neu cell surface receptor antigen with human-specific antibodies (Figure 5b ). Since the SUM-159PT cells were also tagged with GFP, the presence of tumor cells could also be visualized by immunofluorescence (not shown). The primary tumor mass displayed high-level staining for the human antigen, indicating that these cells indeed originated from the injected SUM-159PT cells and do not represent spontaneous tumor formation in these mice. Furthermore, based on the analysis of the lung and liver, tumor cells were detected in lung but not in liver. In lung, there were no clear macro-metastases, only staining of individual cells or cell clusters were observed (Figure 5c ). The quantitative assessment of the spreading of tumor to lung was difficult to measure. Qualitatively, however, staining of cells in lung was observed only upon the presence of adipocytes at the original sites of tumor injection. This indicates that factors from adipocytes may not only increase the levels and rate of tumor progression but may also promote development of metastases as well.
The Adipocyte-enriched type VI collagen promotes GSK3b phosphorylation and increased b-catenin activity All functional readouts described so far with respect to mammary cancer development and progression are the result of exposure to the total complement of adipocytesecreted proteins. This is meaningful since it is a reflection of the complex crosstalk that exists in the mammary microenvironment in vivo. The effect that a stromal cell, such as the adipocyte, has on ductal epithelial cells cannot simply be defined by the actions of a single factor on a single process (i.e. proor antiproliferative, pro-or antiangiogenic, pro-or . However, it is desirable albeit experimentally difficult to define the contribution of a single factor while bearing in mind the limitations with respect to the interpretation of the effects of an isolated factor vs its action in the context of the total complement of secretory proteins. Previously, we reported that collagen VIa3 is a protein highly enriched in adipocytes . There is also evidence suggesting a role for collagen VI in tumorigenesis. To gain insight into the potential signaling capacity of type VI collagen and its effect on MCF-7 cells, we tested whether soluble collagen VI could cause the phosphorylation of key signaling proteins. The pathways studied included the protein kinase B-GSK3b-b catenin axis, the protein kinase A regulated pathways, apoptotic pathways and BAD, the stress-activated SAP kinase, and FAK phosphorylation (adhesion pathways). These proteins were chosen due to the critical role they play in tumorigenesis.
Human MCF-7 cells were incubated with purified human Type VI collagen for 0, 5, or 30 min. Protein extracts were prepared from these cells and subjected to Western blot analysis with various phospho-specific antibodies. Collagen VI induced the phosphorylation of GSK3b (at the Ser9 residue) (Figure 6 ). There was also a small increase of the phosphorylation state of focal adhesion kinase FAK (data not shown). Little change of the phosphorylation state of PKB/AKT was observed. Previous studies in other cell systems have identified focal adhesion kinase FAK as an important adhesion protein whose function is regulated (through phosphorylation) by signals from extracellular matrix stimuli. The induction of GSK3b phosphorylation by collagen VI in MCF-7 cells was more surprising. After 30 min exposure to type VI collagen, there was a significantly higher level of GSK3b in the phosphorylated state compared to no treatment or treatment with similar concentrations of collagen type I, suggesting that the effect is specific for type VI collagen. No detectable phospho-AKT, phospho-BAD, and phospho-SAP kinase could be detected upon collagen treatment after 30 minutes.
The ability of type VI collagen to induce the phosphorylation (and hence inactivation) of GSK3b is consistent with our previous result that total Adipo-CM could promote b-catenin stabilization to a far greater extent than Fibro-CM (in both transformed cells and immortalized, non-transformed ductal epithelial cells). Therefore, additional experiments were performed to verify that the increased GSK3b phosphorylation leads to increased b-catenin-regulated transcriptional activity. Both TCF/LEF luciferase reporter assays, offering a transcriptional read out of b-catenin activity, and metabolic labeling of cells subsequent to type VI stimulation for a measure of b-catenin stability were utilized. From our studies, it was clear that collagen VI can increase the stability of b-catenin protein over time and increase TCF/LEF transcriptional activity (data not shown). Hence, type VI collagen may play a critical role in the modulation of the oncogenic potential of ductal epithelial cells, since increased b-catenin levels spur positive proliferative and tumorigenic effects while acting as a proto-oncogene (Morin, 1999; Behrens, 2000; Lin et al., 2000a; Michaelson and Leder, 2001 ).
Upregulation of type VI a3 collagen during tumor progression
To determine whether type VI collagen-mediated signaling is important in the course of cancer progression, we used immunohistochemistry to determine protein expression levels during tumorigenesis. Figure 7a shows that tumor progression is associated with increased levels of immunoreactive Type VIa3 collagen that is primarily localized around the tumor cells in a transgenic MMTV-Polyoma Middle T antigen mouse model of breast cancer (reviewed in Hutchinson and Muller, 2000) . RT-PCR on MMTV-Polyoma Middle T mammary carcinoma cells and MCF-7 cells showed no evidence of Type VIa3 expression, whereas it could readily be identified from isolated human fat cells (not shown). More importantly, in situ hybridization on a sample similar to a late stage sample used for the immunohistochemistry revealed specific hybridization only in adipocytes and not in tumor cells (Figure 7b,c) . This suggests that breast cancer is associated with an increase in Type VIa3 collagen expression, primarily at the level of the surrounding adipocytes. The data therefore underline the importance of the observations reported above with respect to the stimulation of increased b-catenin activity in MCF-7 cells in response to exposure to purified type VI collagen. Our current hypothesis consists of the notion that collagen VI secreted from adipocytes may act locally and interact with tumor cells, setting off a number of pro-oncogenic signaling pathways. We are presently attempting to dissect out collagen VI's in vivo role during cancer progression.
Discussion
The process of tumorigenesis involves several distinct features (Hanahan and Weinberg, 2000) : self-sufficiency in growth signals, insensitivity to antigrowth signals, tissue invasion and metastasis, limitless replicative potential, sustained angiogenesis, and evasion of apop- Figure 6 The adipocyte-enriched type VI collagen promotes GSK3b phosphorylation. MCF-7 breast cancer cells were serum starved for 3 h and then treated with soluble type VI collagen for 0, 5, and 30 min. Subsequent protein extracts were probed for phosphorylated forms of GSK3b. The effect of type I collagen on GSK3b phosphorylation was also determined as a control. Both type I and type VI collagens were used at 30 mg/ml. Equal protein loading was assessed on the blot by probing for GSK3b. The data shown are a representative example of three independent experiments tosis. Several recent reviews discuss the need to not only study the self-autonomous cellular processes underlying malignancies, but also emphasize the importance of local paracrine factors in the tumor micro-and macroenvironments. Many studies have demonstrated the multifaceted influence that stromal cells and their secreted factors can have on tumorigenesis. Some stromal-epithelial cell interactions can regulate the initial transforming process. Other interactions can promote invasion/metastasis and/or cell survival by inhibiting apoptosis. The effects of heterotypic signaling within various microenvironments are therefore not spatio-temporally limited to specific stages of tumorigenesis, but appear to play a crucial role at every stage of tumor progression. Soluble stromal factors thus influence the growth, development, invasion, and metastasis of these tumors. To that end, a number of groups have initiated studies focusing on the processes by which fibroblasts, myelofibroblasts, macrophages, and other cells act on various tumors including ductal epithelial cell malignancies of the breast (reviewed in Wiseman and Werb, 2002) .
Within the context of the mammary microenvironment, however, very little work has been performed in examining the role that adipocytes play in regulating tumor growth, survival, and metastasis. The few studies published to date have demonstrated repeatedly the importance of the adipose tissue for survival and growth of tumors in vivo. In light of the growing interest in heterotypic signaling in tumorigenesis, we set out to define the molecular interactions between adipocytes and malignant breast ductal epithelial cells that may be responsible for the strict dependence of ductal epithelial cells on surrounding adipose tissue.
The initial conditioned media experiments demonstrated that the entire complement of secretory proteins released by adipocytes has far more profound effects on breast cancer cell survival and proliferation than factors secreted by other cell types. Microarray data point to the regulation of several important transcriptional programs that promote survival and tumorigenesis. The upregulation of matrix metalloproteinase 1 leads to an increased invasive potential. Similarly, the upregulation of A20 and NFkB are antiapoptotic. The transcription factor ATF3 induces increased metastatic potential when overexpressed in breast tumor cells. Additional growth factors, such as IGF II, are also induced. On the other hand, genes that suppress growth and induce apoptosis are downregulated, such as p18, Bard 1, and the mitotic spindle checkpoint genes.
The cell cycle analysis of the conditioned-mediatreated MCF-7 cells also indicates that adipokines could raise proliferative capacity. Increased percentage of cells in S phase indicates the presence of growth promoting factors in the Adipo-CM that caused more cells to pass the G1/S checkpoint. This increase in S phase cells could be due to increased NFkB induction as demonstrated in our microarray and luciferase assays or the upregulation of cyclin D1 transcription as a result of increased NFkB activity. The rise in cyclin D1 levels along with the decrease in p18 leading to increased stability of CDK6 is consistent with these observations. Even the increased levels of free b-catenin may induce cyclin D1 and lead to changes in cell cycle (Lin et al., 2000a) . To determine the extent to which adipokines can induce oncogenes and other tumor-supporting factors, luciferase assays were used, demonstrating that Adipo-CM has a greater impact on inducing AP1, cFOS, and cJUN expression than factors secreted by other cell types. All the above experiments suggest that both replicative potential and evasion of apoptosis can be induced by adipocytes. We also addressed the issue of increased invasive/metastatic and angiogenic potential of breast cancer cells in response to adipokines. Cell migration and woundhealing assays demonstrated that adipocyte-borne factors could specifically increase the motility of several breast cancer cell types. Cell motility is one of the early steps of tissue invasion/metastasis. Furthermore, the secreted factors from adipocytes also greatly promote angiogenesis in breast tumors, as evidenced by their effect on the endothelial cells in vitro. A similar proangiogenic potential of the adipocyte had previously been demonstrated by Spiegelman and colleagues upon exposure of endothelial cells to Adipo-CM, albeit not in comparison to fibroblastsecreted factors (Castellot et al., 1982; Dobson et al., 1990) .
Combined, these experiments demonstrate that the adipocyte plays an important role in the breast microenvironment and has the ability to influence tumor cell behavior. These cells have the potential to shape the local tumor landscape, similar to the ability of fibroblasts (Ruiter et al., 2002) , myoepithelial cells (Batsakis et al., 1983) , and macrophages (Lin et al., 2001a) in the context of mammary and other cancer types. We have additionally established a system that allows for the study of these complex interactions in vivo through the use of a defined adipocyte cell line combined with a fluorescently tagged breast cancer cell line, SUM-159PT cells. These human mammary cells, which are epithelial in origin and highly metastatic, represent a good model for late-stage, estrogen unresponsive tumors. SUM-159PT cells are capable of invading through an 8 mm Matrigel membrane and display a stellate morphology in Matrigel, indicative of a metastatic phenotype. Correlating with this phenotype, secondary tumors have been observed upon inoculation of SUM-159PT cells into the mammary fat pad (Flanagan et al., 1999) . This in vivo system also allows us to measure quantitatively the powerful ability of 3T3-L1 adipocytes to foster growth and metastatic potential of transformed breast ductal epithelial cells. The ability to reconstitute fat pads in vivo that support tumor growth will allow us to manipulate 3T3-L1 cells prior to differentiation in order to overexpress specific factors and assess the potential of these genetically altered adipocytes to promote tumor growth and formation of metastasis. The process of cell-to-cell signaling is a difficult one to address in vitro in ways that are relevant for in vivo processes. While we are aware of the limitations that our experimental approaches offer, we believe that they represent an important first step towards the identification of the most relevant processes that the adipocyte takes active part in over the course of tumor development.
Finally, we have begun to identify individual adipocyte-enriched secretory factors with the potential to influence tumor development. Other groups have shown that leptin, an adipokine predominantly expressed in adipocytes, has a growth-stimulatory effect on MCF-7 cells (Dieudonne et al., 2002) . However, a preliminary study by O'Brien suggests that leptin is also expressed in malignant epithelial cells of the breast (O'Brien et al., 1999) . The presence of leptin in breast cancer cells, acting through an autocrine mechanism, therefore cannot explain the strict dependence of breast cancer cells on surrounding adipose tissue, but much rather eliminates leptin as a critical growth factor originating in adipose tissue in this context.
In contrast to leptin, type VI collagen expression is limited to adipocytes and to a lesser extent to endothelial cells. Type VI collagen expression was identified in adipocytes through a novel subtractive antibody screen . Based on the results of previous screens in other cancer types, we have studied its role in promoting pro-oncogenic pathways in breast cancer cells. We have shown that type VI collagen exerts effects on the phosphorylation of GSK3b in malignant ductal epithelial cells. By signaling the phosphorylation of GSK3b, it allows increased b-catenin stabilization and transcriptional activity. b-catenin promotes many protumorigenic transcriptional programs. Recently, Matrisian and colleagues (Wagenaar et al., 2001) showed that overexpression of various forms of b-catenin in precursor cells could result in increased cellular transformation and immortalization. It is well established that b-catenin levels are often elevated in a variety of malignant cell types (Morin, 1999; Michaelson and Leder, 2001 ) including, but not limited to, colonic tumors. In fact, Michaelson and Leder (2001) recently demonstrated that the wntb-catenin pathway is an important player in mammary tumorigenesis. Normally, b-catenin is regulated by GSK3b (Novak and Dedhar, 1999; Waltzer and Bienz, 1999; Behrens, 2000) . Phosphorylation of b-catenin by GSK3b results in its degradation. This is why we tested the combined effect of various conditioned media as well as the individual effect of collagen VI on GSK3b and b-catenin protein levels in the MCF-7 and hTERT cells. Unpublished data from our lab also suggest that soluble collagen VI is an important stabilizer of cyclin D1 activity, another promoter of tumorigenesis. The effects observed in vitro may therefore be relevant for in vivo tumorigenesis as well, particularly in light of our observation that Type VIa3 expression is significantly upregulated in adipocytes during cancer progression. Future studies will have to address the relative contribution of Type VI collagen towards breast cancer progression in vivo.
